Non Government Organizations
Diabetes and Immune Tolerance
Research into the etiology and potential treatments for diabetes is one of the major areas of research supported by the RUCDR, involving partnerships with a number of agencies. As part of this effort, we isolate peripheral blood mononuclear cells (PBMCs) for cryopreservation, storage, and distribution to the diabetes research community.
The Helmsley Type 1 Diabetes Exchange
The Helmsley Type 1 Diabetes Exchange was launched in 2009 with the goal of dramatically advancing treatment and care for people living with type 1 diabetes. The T1D Exchange BioBank is an initiative to distribute, share and exchange meaningful data that drives collaboration and distributes knowledge across the type 1 community. By centralizing and preserving biological samples, the T1D Exchange hopes to unite all engaged in the search for answers with a world-class resource for the research and study of type 1 diabetes. In partnership with the T1D Exchange, RUCDR has initiated the biobank and will receive and process blood samples from all participating T1D collection sites. For more information, visit our partner's website.